IMA vs TER · rev $9.2M vs P/E 76, rev $2.82B
ImageneBio, Inc. (IMA) versus Teradyne Inc (TER) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Teradyne Inc (TER) is a semiconductor equipment & materials company listed on NASDAQ.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported TER revenue for 2024-12-31 was $2.82B. Net income was $542.4M. Revenue was up 5.4% from 2023-12-31 to 2024-12-31. TER currently screens at market cap $63.96B and trailing P/E 75.7.
IMA currently screens at market cap $64.7M. TER currently screens at market cap $63.96B and trailing P/E 75.7.
Not investment advice. Open the IMA and TER stock pages for the full models.
Not investment advice.